Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51)

Tina Korošec, Jure Ačimovič, Matej Seliškar, Darko Kocjan, Klementina Fon Tacer, Damjana Rozman, Uroš Urleb

Research output: Contribution to journalArticle

31 Scopus citations

Abstract

Novel cholesterol biosynthesis inhibitors, a group of pyridylethanol(phenylethyl)amine derivatives, were synthesized. Sterol profiling assay in the human hepatoma HepG2 cells revealed that compounds target human lanosterol 14α-demethylase (CYP51). Structure-activity relationship study of the binding with the overexpressed human CYP51 indicates that the pyridine binds within the heme binding pocket in an analogy with the azoles.

Original languageEnglish (US)
Pages (from-to)209-221
Number of pages13
JournalBioorganic and Medicinal Chemistry
Volume16
Issue number1
DOIs
StatePublished - Jan 1 2008

Keywords

  • Cholesterol biosynthesis inhibitors
  • Cholesterol intermediates profile
  • Human lanosterol 14α-demethylase (CYP51) inhibitors
  • Pyridylethanolamines

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51)'. Together they form a unique fingerprint.

  • Cite this

    Korošec, T., Ačimovič, J., Seliškar, M., Kocjan, D., Tacer, K. F., Rozman, D., & Urleb, U. (2008). Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51). Bioorganic and Medicinal Chemistry, 16(1), 209-221. https://doi.org/10.1016/j.bmc.2007.10.001